CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • Á¤»ó¼³
  • À¯¹æ°©»ó¼±¾Ï¼¾ÅÍÀå
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : À¯¹æ
  • Á÷ À§: ±³¼ö(À¯¹æ°©»ó¼±¾Ï¼¾ÅÍÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

µî·Ï

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ ´Ù¿î·Îµå
16 ÇØ¿Ü Branched-chain Assay for ER, PR, and HER2 RNA Levels is a Useful Adjunct in the Evaluation of ER, PR, and HER2 in Breast Cancer : JOURNAL OF BREAST CANCER 2010.  
15 ÇØ¿Ü Bilateral primary breast lymphoma. : Chin Med J 2010. Jun.  
14 ÇØ¿Ü Endoscopic thyroidectomy and sentinel lymph node biopsy via an anterior chest approach for papillary thyroid cancer. : Surg Today. 2009.  
13 ÇØ¿Ü Oncoprotein HCCR-1 expression in breast cancer is well correlated with known breast cancer prognostic factors including the HER2 overexpression, p53 mutation, and ER/PR status. BMC Cancer. 2009. Feb.  
12 ÇØ¿Ü Dual action of apolipoprotein E-interacting HCCR-1 oncoprotein and its implication for breast cancer and obesity. : J Cell Mol Med. 2009. Sep.  
11 ÇØ¿Ü Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer. : World J Surg Oncol. 2009. Oct.  
10 ÇØ¿Ü Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy. : World J Surg Oncol. 2009. Oct.  
9 ±¹³» Prognostic significance of HER2 gene amplification according to stage of breast cancer. : J Korean Med Sci 2008. Jun.  
8 ÇØ¿Ü A case of Riedel"s thyroiditis associated with benign nodule: mimic of anaplastic transformation. : Int J Surg 2008. Dec.  
7 ÇØ¿Ü The effect of simulation on recurrence after breast-conserving surgery and radiotherapy: preliminary results. : Cancer Res Treat 2006. Feb.  
ÀÌÀüÆäÀÌÁö À̵¿ 11 12 13 14 15 16 17 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729